Table 4 shows the clinical characteristics of three patients who presented with markedly advanced BA (BA-CA ~ 4.7-5.6 years), compromised PAH and frequent elevations in random LH during treatment. The gene discussed is PLOD1; the disease is pulmonary arterial hypertension.